New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes

New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%. New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%. New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Auromere Ayurvedic Imports Introduces Flower Greeting Cards and Calendars at Natural Products Expo West 2010 Auromère, America’s premium line of Ayurvedic Body Care products, announces the introduction of their new flower greeting cards and calendars at Natural Products Expo West at the Anaheim Convention Center from March 12-14. Auromere Ayurvedic Imports Introduces Flower Greeting Cards and Calendars at Natural Products Expo West 2010 Auromère, America’s premium line of Ayurvedic Body Care products, announces the introduction of their new flower greeting cards and calendars at Natural Products Expo West at the Anaheim Convention Center from March 12-14. Auromere Ayurvedic Imports Introduces Flower Greeting Cards and Calendars at Natural Products Expo West 2010 Auromère, America’s premium line of Ayurvedic Body Care products, announces the introduction of their new flower greeting cards and calendars at Natural Products Expo West at the Anaheim Convention Center from March 12-14. Auromere Ayurvedic Imports Introduces Flower Greeting Cards and Calendars at Natural Products Expo West 2010 Auromère, America’s premium line of Ayurvedic Body Care products, announces the introduction of their new flower greeting cards and calendars at Natural Products Expo West at the Anaheim Convention Center from March 12-14. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Cognis to Submit Article 13.5 Dossier to EFSA on New, Original Science Supporting Health Claims for Xangold® Natural Lutein Esters Cognis Nutrition & Health has announced today that it will submit a dossier to the European Food Safety Authority (EFSA) with additional new science, including studies conducted with its Xangold® branded ingredient. Ask the Experts Exhibits at Natural Products Expo West SupplyExpo The Consultants Association for the Natural Products Industry™ (CANI™), in conjunction with New Hope Natural Media, will sponsor Ask the Experts at Natural Products Expo West SupplyExpo, March 12-14, 2010 at booth 363 in Hall A. Ask the Experts Exhibits at Natural Products Expo West SupplyExpo The Consultants Association for the Natural Products Industry™ (CANI™), in conjunction with New Hope Natural Media, will sponsor Ask the Experts at Natural Products Expo West SupplyExpo, March 12-14, 2010 at booth 363 in Hall A. Ask the Experts Exhibits at Natural Products Expo West SupplyExpo The Consultants Association for the Natural Products Industry™ (CANI™), in conjunction with New Hope Natural Media, will sponsor Ask the Experts at Natural Products Expo West SupplyExpo, March 12-14, 2010 at booth 363 in Hall A. Ask the Experts Exhibits at Natural Products Expo West SupplyExpo The Consultants Association for the Natural Products Industry™ (CANI™), in conjunction with New Hope Natural Media, will sponsor Ask the Experts at Natural Products Expo West SupplyExpo, March 12-14, 2010 at booth 363 in Hall A. Bricker Labs and DSM Nutritional Products Introduce ResForte(TM), the Highest Potency Trans-Resveratrol Softgel Available Phoenix-based Bricker Labs has announced launch of the highest potency trans-resveratrol softgel capsule available on the market called ResForte(TM). Bricker Labs and DSM Nutritional Products Introduce ResForte(TM), the Highest Potency Trans-Resveratrol Softgel Available Phoenix-based Bricker Labs has announced launch of the highest potency trans-resveratrol softgel capsule available on the market called ResForte(TM). Bricker Labs and DSM Nutritional Products Introduce ResForte(TM), the Highest Potency Trans-Resveratrol Softgel Available Phoenix-based Bricker Labs has announced launch of the highest potency trans-resveratrol softgel capsule available on the market called ResForte(TM). Bricker Labs and DSM Nutritional Products Introduce ResForte(TM), the Highest Potency Trans-Resveratrol Softgel Available Phoenix-based Bricker Labs has announced launch of the highest potency trans-resveratrol softgel capsule available on the market called ResForte(TM). Bricker Labs and DSM Nutritional Products Introduce ResForte(TM), the Highest Potency Trans-Resveratrol Softgel Available Phoenix-based Bricker Labs has announced launch of the highest potency trans-resveratrol softgel capsule available on the market called ResForte(TM). XSTO SOLUTIONS Announces Exclusive Marketing Agreement of AGD Nutrition’s Vitamin D and Associated Product Line XSTO SOLUTIONS, LLC (XSTO) and ADG NUTRITION, LLC (AGD), jointly announce a new sales and marketing agreement between the two companies. XSTO SOLUTIONS Announces Exclusive Marketing Agreement of AGD Nutrition’s Vitamin D and Associated Product Line XSTO SOLUTIONS, LLC (XSTO) and ADG NUTRITION, LLC (AGD), jointly announce a new sales and marketing agreement between the two companies. XSTO SOLUTIONS Announces Exclusive Marketing Agreement of AGD Nutrition’s Vitamin D and Associated Product Line XSTO SOLUTIONS, LLC (XSTO) and ADG NUTRITION, LLC (AGD), jointly announce a new sales and marketing agreement between the two companies. XSTO SOLUTIONS Announces Exclusive Marketing Agreement of AGD Nutrition’s Vitamin D and Associated Product Line XSTO SOLUTIONS, LLC (XSTO) and ADG NUTRITION, LLC (AGD), jointly announce a new sales and marketing agreement between the two companies. Scientific Food Solutions and Sabinsa Extend Semi-Exclusive License Agreement Including BioPerine(R) in FAST-C(TM) The BioPerine® Patent and Trademark License Agreement between Scientific Food Solutions and Sabinsa Corporation for “field of use in dietary supplements compositions comprised of ascorbic acid and Vitamin C” incorporating BioPerine in FAST-C™ has been renewed. Scientific Food Solutions and Sabinsa Extend Semi-Exclusive License Agreement Including BioPerine(R) in FAST-C(TM) The BioPerine® Patent and Trademark License Agreement between Scientific Food Solutions and Sabinsa Corporation for “field of use in dietary supplements compositions comprised of ascorbic acid and Vitamin C” incorporating BioPerine in FAST-C™ has been renewed. Scientific Food Solutions and Sabinsa Extend Semi-Exclusive License Agreement Including BioPerine(R) in FAST-C(TM) The BioPerine® Patent and Trademark License Agreement between Scientific Food Solutions and Sabinsa Corporation for “field of use in dietary supplements compositions comprised of ascorbic acid and Vitamin C” incorporating BioPerine in FAST-C™ has been renewed. Scientific Food Solutions and Sabinsa Extend Semi-Exclusive License Agreement Including BioPerine(R) in FAST-C(TM) The BioPerine® Patent and Trademark License Agreement between Scientific Food Solutions and Sabinsa Corporation for “field of use in dietary supplements compositions comprised of ascorbic acid and Vitamin C” incorporating BioPerine in FAST-C™ has been renewed. Scientific Food Solutions and Sabinsa Extend Semi-Exclusive License Agreement Including BioPerine(R) in FAST-C(TM) The BioPerine® Patent and Trademark License Agreement between Scientific Food Solutions and Sabinsa Corporation for “field of use in dietary supplements compositions comprised of ascorbic acid and Vitamin C” incorporating BioPerine in FAST-C™ has been renewed. Scientific Food Solutions and Sabinsa Extend Semi-Exclusive License Agreement Including BioPerine(R) in FAST-C(TM) The BioPerine® Patent and Trademark License Agreement between Scientific Food Solutions and Sabinsa Corporation for “field of use in dietary supplements compositions comprised of ascorbic acid and Vitamin C” incorporating BioPerine in FAST-C™ has been renewed. Top of the News: AHPA Announces Winners of 2010 AHPA Awards The American Herbal Products Association (AHPA) is proud to announce the winners of its fifth annual AHPA Awards to recognize individuals and companies making substantive, positive contributions to the herbal products industry Top of the News: AHPA Announces Winners of 2010 AHPA Awards The American Herbal Products Association (AHPA) is proud to announce the winners of its fifth annual AHPA Awards to recognize individuals and companies making substantive, positive contributions to the herbal products industry Zero Fat Healthy White Chicken Snack (with Red Vegetables) Karela Bitter Gourd	NEW YORK — Nutrition 21, Inc. (Nasdaq: NXXI) reported today results from a new clinical study that add to the growing body of clinical data demonstrating that daily supplementation with Diachrome®, a combination of chromium picolinate and biotin, can significantly reduce cardiovascular disease risk factors in people with type 2 diabetes. Findings from the randomized double-blind, placebo-controlled trial, were presented at the 2nd International Symposium on Triglycerides and HDL: Role in Cardiovascular Disease and the Metabolic Syndrome in New York, a meeting organized by the Giovanni Lorenzini Medical Foundation that is attended by both U.S. and international cardiologists and lipid specialists. The study results presented include an analysis of subjects with type 2 diabetes who were moderately obese and taking oral antidiabetic medications. When Diachrome was added to daily treatment regimens, the atherogenic index of plasma (AIP), a predictive marker for cardiovascular disease that examines triglyceride and HDL cholesterol levels (good cholesterol), was significantly lower compared with the placebo group. The AIP in the Diachrome group dropped from 1.15 to 1.06, while it increased from 1.27 to 1.55 in the placebo group. A significant difference in triglycerides and cholesterol levels was also observed between the groups. “These results support previous findings that Diachrome can serve as a safe and effective nutritional adjunct to medication in helping to lower triglyceride and cholesterol levels in people with type 2 diabetes,” said study investigator Jeffrey Geohas, Medical Director, Chicago Research Center. “The ability for Diachrome to reduce these risk factors is important in this population because heart disease is the leading cause of death in patients who suffer from diabetes,” said Dr. Geohas. Nutrition 21, Inc. conducted the study in collaboration with the Chicago Research Center. “This study underscores the promise of Diachrome in helping to prevent cardiovascular disease in people with type 2 diabetes,” said Gail Montgomery, president and CEO of Nutrition 21. “As we share the wealth of clinical data demonstrating the benefits of Diachrome for people with type 2 diabetes, we anticipate that physicians will be eager to incorporate the product into clinical practice.” Diachrome is a nutritional supplement specifically formulated for people with diabetes. It contains 600 mcg of chromium as Chromax® chromium picolinate and 2 mg of biotin. These two compounds are both Generally Recognized as Safe (GRAS) for use as ingredients in food and supplements. It is available for purchase by calling 1-866-DIACHROME or at www.diachrome.com. About the Atherogenic Index of Plasma AIP is an index used to measure the atherogenicity of plasma by examining the ratio of triglycerides to HDL cholesterol (good cholesterol). It identifies the risk for atherogenesis (fat build up in the arteries), particularly in diabetes patients and is recognized as a predictor for heart attack. The measurement reflects the delicate balance of metabolic interactions with the whole lipoprotein complex. Physicians currently utilize AIP in clinical practice to quantify response to therapeutic interventions. About Nutrition 21 Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome, which is available through diabetes educators or at www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at www.nutrition21.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software